电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

SET/TAF-I 抗体 (Cy3)

This anti-SET/TAF-I antibody is a 兔 多克隆 antibody detecting SET/TAF-I in WB 和 FACS. Suitable for 人, 小鼠 和 大鼠.
产品编号 ABIN760169
发货至: 中国

Quick Overview for SET/TAF-I 抗体 (Cy3) (ABIN760169)

抗原

See all SET/TAF-I (SET) 抗体
SET/TAF-I (SET) (SET Nuclear Oncogene (SET))

适用

  • 71
  • 36
  • 35
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
人, 小鼠, 大鼠

宿主

  • 66
  • 3
  • 2

克隆类型

  • 56
  • 14
多克隆

标记

  • 36
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SET/TAF-I antibody is conjugated to Cy3

应用范围

  • 49
  • 23
  • 20
  • 14
  • 13
  • 9
  • 6
  • 6
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Flow Cytometry (FACS)
  • 交叉反应

    预测反应

    Mouse,Rat,Dog,Cow,Horse,Chicken,Rabbit

    纯化方法

    Purified by Protein A.

    免疫原

    KLH conjugated synthetic peptide derived from human SET

    亚型

    IgG
  • 应用备注

    FCM: 1:20-100, IF(IHC-P): 1:50-200
    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    1 mg/mL

    缓冲液

    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    -20 °C

    储存方法

    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

    有效期

    12 months
  • 抗原

    SET/TAF-I (SET) (SET Nuclear Oncogene (SET))

    别名

    Set

    背景

    Optional[synonyms]: SET_HUMAN, Protein SET, HLA-DR-associated protein II, Inhibitor of granzyme A-activated DNase (IGAAD), PHAPII, Phosphatase 2A inhibitor I2PP2A (I-2PP2A), Template-activating factor I (TAF-I), 2PP2A, IGAAD, MRD58, TAF-I, I2PP2A, IPP2A2, PHAPII, TAF-IBETA,

    基因ID

    6418

    UniProt

    Q01105

    途径

    Apoptosis
You are here:
Chat with us!